Chiracon
Chiracon GmbH is a pharmaceutical ingredient manufacturer based in Brandenburg with over 25 years of experience. Founded in 1998, the company specializes in the production of high-quality intermediates and active pharmaceutical ingredients (APIs) using innovative manufacturing processes. They offer comprehensive services including contract research, process development, scale-up, stability studies, and clinical trial material production. The company is committed to building the European future of active ingredient manufacturing in Brandenburg, with a focus on environmental standards and modern facilities. Chiracon actively participates in industry events such as CPhI and Chemspec, and has received awards like the Brandenburg Future Prize 2022. They are also expanding with a new state-of-the-art production and office building near the Luckenwalde biotech park.
Industries
Nr. of Employees
small (1-50)
Chiracon
Services
Manufacture of active pharmaceutical ingredients to GMP quality for the pharmaceutical industry and large pharmacies.
Contract research focused on synthesis development and optimization for projects from milligram to kilogram scale.
Scale-up services to adapt laboratory syntheses for production-scale manufacturing.
Synthesis and supply of chemical intermediates, with capabilities for chiral intermediates used in synthesis and technical applications.
High-standard stability studies performed according to ICH guidelines and customer-specific requirements.
Production of drug substance for clinical trials, including preparation of associated documentation.
Manufacture of active pharmaceutical ingredients to GMP quality for the pharmaceutical industry and large pharmacies.
Contract research focused on synthesis development and optimization for projects from milligram to kilogram scale.
Scale-up services to adapt laboratory syntheses for production-scale manufacturing.
Synthesis and supply of chemical intermediates, with capabilities for chiral intermediates used in synthesis and technical applications.
High-standard stability studies performed according to ICH guidelines and customer-specific requirements.
Production of drug substance for clinical trials, including preparation of associated documentation.
Expertise Areas
- API manufacturing (GMP)
- Scale-up and technology transfer
- Contract research and synthesis optimization
- Chiral intermediate synthesis
Key Technologies
- GMP-compliant API manufacturing
- Laboratory-to-production scale-up
- Chiral synthesis
- Synthesis route development
News & Updates
Chiracon GmbH participated in Chemspec Europe 2025 in Cologne, showcasing their presence at a leading international trade fair for fine and specialty chemicals.
The new building's interior fit-out is progressing, and the exterior is taking shape, with preparations for commissioning underway.
The building shell of the new production and administrative facility in Luckenwalde has been successfully completed, with interior work following.
Chiracon exhibited at the 35th international trade fair for pharmaceutical ingredients in Milan, October 2024.
The groundbreaking ceremony for the new facility in Luckenwalde took place on June 13, 2024.
Construction progress on the new production plant, with the first external wall erected.
Chiracon GmbH participated in Chemspec Europe 2025 in Cologne, showcasing their presence at a leading international trade fair for fine and specialty chemicals.
The new building's interior fit-out is progressing, and the exterior is taking shape, with preparations for commissioning underway.
The building shell of the new production and administrative facility in Luckenwalde has been successfully completed, with interior work following.
Chiracon exhibited at the 35th international trade fair for pharmaceutical ingredients in Milan, October 2024.
The groundbreaking ceremony for the new facility in Luckenwalde took place on June 13, 2024.
Construction progress on the new production plant, with the first external wall erected.